相关实验视频
Updated: Jun 21, 2025

04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
918
外染色体圆形DNA通过FAM84B/CDKN1B/MYC/WWP1轴促进前列腺癌的进展
Wei Jin1, Zhenqun Xu1, Yan Song1
1Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Cellular & molecular biology letters
|July 12, 2024
概括
外染色体圆形DNA (eccDNA) 诱导FAM84B,它通过MYC/WWP1通路降解CDKN1B来加速前列腺癌 (PCa) 的进展. 抑制eccDNA合成可以减少FAM84B和PCa的生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 染色体外圆形DNA (eccDNA) 携带致癌基因,并与癌症发展有关.
- FAM84B是一种可能受到eccDNA影响的基因,正在研究其在前列腺癌 (PCa) 中的作用.
研究的目的:
- 研究eccDNA诱导的FAM84B在前列腺癌进展中的作用.
- 阐明参与FAM84B介导PCa开发的分子机制和生物分子.
主要方法:
- 使用PCR验证eccDNA和FAM84B转录.
- 在eccDNA抑制时分析FAM84B表达和PCa细胞行为 (生长,转移).
- 使用ChIP-qPCR,双露西法酶,Co-IP和救援分析对FAM84B/MYC/WWP1/CDKN1B分子轴的研究.
主要成果:
- 抑制eccDNA合成下调FAM84B,减少PCa细胞生长和转移.
- FAM84B激活了MYC表达,以β-catenin依赖的方式促进了WWP1转录.
- 由MYC驱动的WWP1促进了CDKN1B的无处不在和降解,释放了MYC的抑制并加速了PCa的进展.
结论:
- 由eccDNA诱导的FAM84B通过MYC/WWP1通路调解CDKN1B降解来驱动PCa的进展.
- 针对eccDNA-FAM84B轴为前列腺癌提供了一个潜在的治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K

